[1] [1] WANG F, WANG Y, ZHANG X, et al. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery［J］. Journal of Controlled Release:Official Journal of the Controlled Release Society, 2014, 174(8): 126-136.

[2] [2] FORD K G, SOUBERBIELLE B E, DARLING D, et al. Protein transduction:an alternative to genetic intervention［J］. Gene Therapy, 2001, 8(1): 1-4.

[3] [3] SCHWARZE S R, DOWDY S F. In vivo protein transduction:intracellular delivery of biologically active proteins, compounds and DNA［J］. Trends in Pharmacological Sciences, 2000, 21(2): 45-48.

[4] [4] MUNIZ L, EGLOFF S, UGHY B, et al. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat［J］. PLoS Pathogens, 2010, 6(10): e1001152.

[5] [5] PARK J, RYU J, JIN L H, et al. 9-polylysine protein transduction domain:enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin［J］. Molecules and Cells, 2002, 13(2): 202-208.

[6] [6] GREEN M, LOEWENSTEIN P M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein［J］. Cell, 1988, 55(6): 1179-1188.

[7] [7] FRANKEL A D, PABO C O. Cellular uptake of the tat protein from human immunodeficiency virus［J］. Cell, 1988, 55(6): 1189-1193.

[8] [8] REGBERG J, SRIMANEE A, LANGEL U. Applications of cell-penetrating peptides for tumor targeting and future cancer therapies［J］. Pharmaceuticals, 2012, 5(9): 991-1007.

[9] [9] SEEBACH D, NAMOTO K, MAHAJAN Y R, et al. Chemical and biological investigations of beta-oligoarginines［J］. Chemistry & Biodiversity, 2004, 1(1): 65-97.

[10] [10] VIVES E, BRODIN P, LEBLEU B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus［J］. The Journal of Biological Chemistry, 1997, 272(25): 16010-160107.

[11] [11] WENDER P A, MITCHELL D J, PATTABIRAMAN K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake:peptoid molecular transporters［J］. Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(24): 13003-13008.

[12] [12] HALLBRINK M, OEHLKE J, PAPSDORF G, et al. Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration［J］. Biochimica et Biophysica Acta, 2004, 1667(2): 222-228.

[13] [13] Xiong jiawan. Penetrating effect of R9-EGFP green fluorescent protein［D］, Changsha:Hunan university, 2015.

[14] [14] MARGUS H, PADARI K, POOGA M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery［J］. Molecular therapy:the journal of the American Society of Gene Therapy, 2012, 20(3): 525-533.

[15] [15] QIAN Z, DOUGHERTY P G, PEI D. Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore［J］. Chemical Communications, 2015, 51(11): 2162-21625.

[16] [16] LINDGREN M, ROSENTHAL-AIZMAN K, SAAR K, et al. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide［J］. Biochemical Pharmacology, 2006, 71(4): 416-425.

[17] [17] MELONI B P, CRAIG A J, MILECH N, et al. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures［J］. Cellular and Molecular Neurobiology, 2014, 34(2): 173-181.

[18] [18] TAVERNER A, DONDI R, ALMANSOUR K, et al. Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation［J］. Journal of Controlled Release:Official Journal of the Controlled Release Society, 2015, 210(11): 189-197.

[19] [19] ZOLOTAREVSKY Y, HECHT G, KOUTSOURIS A, et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease［J］. Gastroenterology, 2002, 123(1): 163-172.

[20] [20] SONTHEIMER E J. Assembly and function of RNA silencing complexes［J］. Nature Reviews Molecular Cell Biology, 2005, 6(2): 127-138.

[21] [21] YU jingwei. The study of scale purification and anti-tumor efiicacy of R9-FOXM1-N recombinant protein［D］. Changsha:Hunan University, 2017.